Amadix
Amadix is a biopharmaceutical company specialised in cancer diagnosis. Its products address unmet medical needs in oncology, such as colorectal cancer and advanced adenoma diagnosis in blood.
- biotechnology
- horizon europe
- sustainable development goals
- dt and ls
- woman founder
- testing
- developer tools
- oncology
- eit ecosystem
- predictive analytics
- medical testing
- eit health
- eit supernovas
- eicfund
- investor network (eit health)
- biopsy
- investor network 2020 (eit health)
- digital sandbox (eit health)
- digital sandbox 2020 (eit health)
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | investor investor investor investor | €0.0 | round |
| investor | €0.0 | round | |
| investor investor investor | €0.0 | round | |
| investor | €0.0 | round | |
| investor investor | €0.0 | round | |
| N/A | €0.0 | round | |
| investor | €0.0 | round | |
| investor | €0.0 | round | |
| investor | €0.0 | round | |
| investor | €0.0 | round | |
| investor | €0.0 | round | |
| investor investor | €0.0 | round | |
| investor | €0.0 | round | |
* | €15.0m | Debt | |
| Total Funding | 000k | ||
Related Content
Developer of medical technologies designed to detect tumours years in advance, before the symptoms appear. The company's technologies are oriented towards non-invasive early cancer detection, avoiding the complications of existing invasive procedures, as tumour biopsies, enabling doctors to provide suitable treatment to the patient.
Keywords: Pharmaceuticals and Biotechnology, Artificial Inteligence, Cancer Detection, Cancer Diagnostic System, Diagnostic Tools, Disruptive Diagnostic Technology, Oncology Diagnostic Test, Tumor Detection.
Tech stack
Investments by Amadix
Edit